Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: The artificial pancreas ski study

Diabetes Care

Volumn 40, Issue 12, 2017, Pages 1644-1650

  Breton, Marc D ^a   Cherñavvsky, Daniel R ^a   Forlenza, Gregory P ^b   DeBoer, Mark D ^a   Robic, Jessica ^a   Wadwa, R Paul ^b   Messer, Laurel H ^b   Kovatchev, Boris P ^a   Maahs, David M ^b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ANTERIOR CRUCIATE LIGAMENT RUPTURE; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; COLORADO; DISEASE DURATION; DISTAL TIBIA FRACTURE; EXERCISE; EXERCISE INTENSITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KNEE INJURY; MALE; PHYSICAL ACTIVITY; SKIING; VIRGINIA; WRIST FRACTURE; ADOLESCENT; ARTIFICIAL PANCREAS; BLOOD; BODY MASS; COLD; CONTROLLED STUDY; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SEASON; TREATMENT OUTCOME;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; CHILD; COLD TEMPERATURE; COLORADO; DIABETES MELLITUS, TYPE 1; EXERCISE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIA; PANCREAS, ARTIFICIAL; SEASONS; SKIING; TREATMENT OUTCOME; VIRGINIA;

EID: 85036652786     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-0883     Document Type: Article

References (30)

1. Miller KM, Foster NC, Beck RW, et al.; T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015;38:971-978
2. Thabit H, Hovorka R. Coming of age: the artificial pancreas for type 1 diabetes. Diabetologia 2016;59:1795-1805
3. Kovatchev B, Tamborlane WV, Cefalu WT, Cobelli C. The artificial pancreas in 2016: a digital treatment ecosystem for diabetes. Diabetes Care 2016;39:1123-1126
4. Doyle FJ 3rd, Huyett LM, Lee JB, Zisser HC, Dassau E. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014; 37:1191-1197
5. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751
6. Kovatchev BP, Renard E, Cobelli C, et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 2014;37:1789-1796
7. Anderson SM, Raghinaru D, Pinsker JE, et al.; Control to Range Study Group. Multinational home use of closed-loop control is safe and effective. Diabetes Care 2016;39:1143-1150
8. Keith-Hynes P, Guerlain S, Mize B, et al. DiAs user interface: a patient-centric interface for mobile artificial pancreas systems. J Diabetes Sci Technol 2013;7:1416-1426
9. Keith-Hynes P, Mize B, Robert A, Place J. The Diabetes Assistant: a smartphone-based system for real-time control of blood glucose. Electronics 2014;3:609-623
10. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closedloop insulin delivery versus semiautomated hybrid control in pediatric patientswith type 1 diabetes using an artificialpancreas. Diabetes Care 2008;31:934-939
11. Elleri D, Allen JM, Nodale M, et al. Automated overnight closed-loop glucose control in young children with type 1 diabetes. Diabetes Technol Ther 2011;13:419-424
12. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371:313-325
13. Ly TT, Breton MD, Keith-Hynes P, et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care 2014;37:2310-2316
14. Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 2015;373:2129-2140
15. Bergenstal RM, Garg S, Weinzimer SA, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 2016; 316:1407-1408
16. Toni S, Reali MF, Barni F, Lenzi L, Festini F. Managing insulin therapy during exercise in type 1 diabetesmellitus. Acta Biomed 2006;77(Suppl. 1): 34-40
17. Breton MD, Brown SA, Karvetski CH, et al. Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. Diabetes Technol Ther 2014;16:506-511
18. Roberts AJ, Taplin CE. Exercise in youth with type 1 diabetes. Curr Pediatr Rev 2015;11:120-125
19. Sherr JL, Cengiz E, Palerm CC, et al. Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care 2013;36:2909-2914
20. Ly TT, Buckingham BA, DeSalvo DJ, et al. Dayand-night closed-loop control using the unified safety system in adolescents with type 1 diabetes at camp. Diabetes Care 2016;39:e106-e107
21. Place J, Robert A, Ben Brahim N, et al. DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials. J Diabetes Sci Technol 2013;7:1427-1435
22. Maahs DM, Buckingham BA, Castle JR, et al. Outcomemeasures for artificial pancreas clinical trials: a consensus report. Diabetes Care 2016;39:1175-1179
23. Weissberg-Benchell J, Hessler D, Polonsky WH, Fisher L. Psychosocial impact of the bionic pancreas during summer camp. J Diabetes Sci Technol 2016;10:840-844
24. Del Favero S, Boscari F, Messori M, et al. Randomized summer camp crossover trial in 5-to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe. Diabetes Care 2016; 39:1180-1185
25. Russell SJ, Hillard MA, Balliro C, et al. Day and night glycaemic controlwith a bionic pancreas versus conventional insulin pump therapy in preadolescent childrenwith type 1diabetes: a randomisedcrossover trial. Lancet Diabetes Endocrinol 2016;4:233-243
26. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833
27. DeBoer MD, Cherñavvsky DR, Topchyan K, Kovatchev BP, Francis GL, Breton MD. Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D. Pediatr Diabetes 2017;18:540-546
28. Patel NS, Van Name MA, Cengiz E, et al. Mitigating reductions in glucose during exercise on closed-loop insulin delivery: the Ex-Snacks Study. Diabetes Technol Ther 2016;18:794-799
29. Taleb N, Emami A, Suppere C, et al. Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial. Diabetologia 2016;59: 2561-2571
30. Jacobs PG, El Youssef J, Reddy R, et al. Randomized trial of adual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy. Diabetes Obes Metab 2016;18:1110-1119